ResearcherInsermActive in the last 2 years
Benoît Immordino
Matched on OpenAlex author ID A5076314753. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 29
2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper
Papers 6
- The emerging role of AXL in pancreatic cancer: Biomarker potential and therapeutic targeting to counteract drug resistance. Co-author DOI 10.1016/j.drup.2026.101408↗
- Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model systems. Co-author DOI 10.1016/j.semcancer.2024.09.002↗
- Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13046-024-03090-z↗
- "Depart from evil, and do good": Turning Axl from uncontrolled tumorigenic gene to biomarker for early detection of pancreatic cancer. Co-author DOI 10.1016/j.critrevonc.2022.103659↗
- Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer. First author DOI 10.3390/diagnostics12020286↗
- CX-5461 Inhibits Pancreatic Ductal Adenocarcinoma Cell Growth, Migration and Induces DNA Damage. Co-author DOI 10.3390/molecules24244445↗
Closest collaborators
The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Elisa Giovannetti · 6 shared papers, 2019–2026 · strength 1.12
- Paper The emerging role of AXL in pancreatic cancer: Biomarker potential and therapeutic targeting to counteract drug resista… DOI 10.1016/j.drup.2026.101408↗
- Paper Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model sys… DOI 10.1016/j.semcancer.2024.09.002↗
- Paper Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer. DOI 10.3390/diagnostics12020286↗
- Annalisa Comandatore · 4 shared papers, 2022–2026 · strength 0.81
- Paper The emerging role of AXL in pancreatic cancer: Biomarker potential and therapeutic targeting to counteract drug resista… DOI 10.1016/j.drup.2026.101408↗
- Paper Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer. DOI 10.3390/diagnostics12020286↗
- Paper Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-024-03090-z↗
- Luca Morelli · 4 shared papers, 2022–2026 · strength 0.81
- Paper The emerging role of AXL in pancreatic cancer: Biomarker potential and therapeutic targeting to counteract drug resista… DOI 10.1016/j.drup.2026.101408↗
- Paper Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer. DOI 10.3390/diagnostics12020286↗
- Paper Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-024-03090-z↗
- Mahrou Vahabi · 2 shared papers, 2024–2026 · strength 0.49
- Paper The emerging role of AXL in pancreatic cancer: Biomarker potential and therapeutic targeting to counteract drug resista… DOI 10.1016/j.drup.2026.101408↗
- Paper Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-024-03090-z↗
- Mafalda Angelica Rocco · 1 shared paper, 2026 · strength 0.33
- Mjriam Capula · 2 shared papers, 2022 · strength 0.32
- Paper Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer. DOI 10.3390/diagnostics12020286↗
- Paper "Depart from evil, and do good": Turning Axl from uncontrolled tumorigenic gene to biomarker for early detection of pan… DOI 10.1016/j.critrevonc.2022.103659↗
- Ingrid Garajová · 2 shared papers, 2022 · strength 0.32
- Paper Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer. DOI 10.3390/diagnostics12020286↗
- Paper "Depart from evil, and do good": Turning Axl from uncontrolled tumorigenic gene to biomarker for early detection of pan… DOI 10.1016/j.critrevonc.2022.103659↗
- Rita Balsano · 2 shared papers, 2022 · strength 0.32
- Paper Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer. DOI 10.3390/diagnostics12020286↗
- Paper "Depart from evil, and do good": Turning Axl from uncontrolled tumorigenic gene to biomarker for early detection of pan… DOI 10.1016/j.critrevonc.2022.103659↗
- Macarena Perán · 1 shared paper, 2024 · strength 0.19
- Manoj Amrutkar · 1 shared paper, 2024 · strength 0.19
- Naomi Walsh · 1 shared paper, 2024 · strength 0.19
- Cristina P. R. Xavier · 1 shared paper, 2024 · strength 0.19
- Rita Rebelo · 1 shared paper, 2024 · strength 0.19
- Alessandro Gregori · 1 shared paper, 2024 · strength 0.19
- Belén Toledo · 1 shared paper, 2024 · strength 0.19
- Giulia Lencioni · 1 shared paper, 2024 · strength 0.19
- Justo Pastor Castano · 1 shared paper, 2024 · strength 0.19
- Jisce R. Puik · 1 shared paper, 2024 · strength 0.16
- Daniel Liu · 1 shared paper, 2024 · strength 0.16
- Jonathan Krell · 1 shared paper, 2024 · strength 0.16
- Long R. Jiao · 1 shared paper, 2024 · strength 0.16
- Marc G. Besselink · 1 shared paper, 2024 · strength 0.16
- Geert Kazemier M · 1 shared paper, 2024 · strength 0.16
- Rutger‐Jan Swijnenburg · 1 shared paper, 2024 · strength 0.16
- Adam Enver Frampton · 1 shared paper, 2024 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.